PlainRecalls
FDA Drug Critical Class I Terminated

Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA

Reported: December 28, 2016 Initiated: August 19, 2016 #D-0215-2017

Product Description

Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA

Reason for Recall

Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs

Details

Recalling Firm
Impax Laboratories, Inc.
Units Affected
3,074 boxes (30 count boxes)
Distribution
Distributed Nationwide
Location
Hayward, CA

Frequently Asked Questions

What product was recalled?
Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA. Recalled by Impax Laboratories, Inc.. Units affected: 3,074 boxes (30 count boxes).
Why was this product recalled?
Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs
Which agency issued this recall?
This recall was issued by the FDA Drug on December 28, 2016. Severity: Critical. Recall number: D-0215-2017.